{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:44:30Z","timestamp":1774611870773,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["106 995\/Z\/15\/Z"],"award-info":[{"award-number":["106 995\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NF-SI-0514\u201310091"],"award-info":[{"award-number":["NF-SI-0514\u201310091"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jpeds.2023.02.013","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T21:01:29Z","timestamp":1677704489000},"page":"113367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Neurodevelopmental Abnormalities in Patients with Familial Hypocalciuric Hypercalcemia Type 3"],"prefix":"10.1016","volume":"257","author":[{"given":"Amish","family":"Chinoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mars","family":"Skae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadil M.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh V.","family":"Thakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Zulf","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Padidela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2023.02.013_bib1","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.jpeds.2023.02.013_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jpeds.2023.02.013_bib3","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/hmg\/ddv226","article-title":"Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects","volume":"24","author":"Hannan","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpeds.2023.02.013_bib4","doi-asserted-by":"crossref","first-page":"E1311","DOI":"10.1210\/jc.2014-1120","article-title":"Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations","volume":"99","author":"Hendy","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2023.02.013_bib5","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2023.02.013_bib6","first-page":"7312894","article-title":"Clinical and biochemical features in a case of familial hypocalciuric hypercalcemia type 3 with AP2S1 gene mutation in codon Arg15His","volume":"2020","author":"Aashiq","year":"2020","journal-title":"Case Rep Pediatr"},{"key":"10.1016\/j.jpeds.2023.02.013_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12020-017-1241-5","article-title":"Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia","volume":"55","author":"Szalat","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.jpeds.2023.02.013_bib8","doi-asserted-by":"crossref","first-page":"E1946","DOI":"10.1210\/jc.2013-3105","article-title":"Determination of reference intervals for serum total calcium in the vitamin D-replete pediatric population","volume":"98","author":"Roizen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2023.02.013_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1352\/0895-8017(2001)106<0162:DVOTVS>2.0.CO;2","article-title":"Discriminant validity of the Vineland Scales: score profiles of individuals with mental retardation and a specific disorder","volume":"106","author":"Balboni","year":"2001","journal-title":"Am J Ment Retard"},{"key":"10.1016\/j.jpeds.2023.02.013_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s10803-015-2533-3","article-title":"The vineland-II in preschool children with autism spectrum disorders: an item content category analysis","volume":"46","author":"Balboni","year":"2016","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.jpeds.2023.02.013_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10803-004-1033-7","article-title":"The psychometric properties of the Vineland Adaptive Behavior Scales in children and adolescents with mental retardation","volume":"35","author":"de Bildt","year":"2005","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.jpeds.2023.02.013_bib13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ridd.2008.09.001","article-title":"Reliability and validity of the Vietnamese Vineland adaptive behavior scales with preschool-age children","volume":"30","author":"Goldberg","year":"2009","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.jpeds.2023.02.013_bib14","first-page":"151","article-title":"The autistic phenotype in down syndrome: differences in adaptive behaviour versus Down syndrome alone and autistic disorder alone","volume":"26","author":"Dressler","year":"2011","journal-title":"Funct Neurol"},{"key":"10.1016\/j.jpeds.2023.02.013_bib15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10803-014-2256-x","article-title":"Adaptive profiles in autism and other neurodevelopmental disorders","volume":"45","author":"Mouga","year":"2015","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.jpeds.2023.02.013_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13023-017-0648-7","article-title":"Vineland adaptive behavior scales to identify neurodevelopmental problems in children with Congenital Hyperinsulinism (CHI)","volume":"12","author":"Salomon-Estebanez","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jpeds.2023.02.013_bib17","series-title":"Vineland adaptive behavior Scales, Second Edition (Vineland-II)","author":"Sparrow","year":"2005"},{"key":"10.1016\/j.jpeds.2023.02.013_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/01.WNL.0000031431.81555.16","article-title":"Practice parameter: evaluation of the child with global developmental delay: report of the Quality standards subcommittee of the American Academy of Neurology and the practice Committee of the child Neurology Society","volume":"60","author":"Shevell","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2023.02.013_bib19","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1542\/peds.2006-2089L","article-title":"Lifetime prevalence of learning disability among US children","volume":"119","author":"Altarac","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2023.02.013_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/aur.239","article-title":"Global prevalence of autism and other pervasive developmental disorders","volume":"5","author":"Elsabbagh","year":"2012","journal-title":"Autism Res"},{"key":"10.1016\/j.jpeds.2023.02.013_bib21","doi-asserted-by":"crossref","first-page":"744709","DOI":"10.3389\/fpsyt.2021.744709","article-title":"Prevalence of autism spectrum disorder and Co-morbidities in children and adolescents: a systematic Literature review","volume":"12","author":"Bougeard","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jpeds.2023.02.013_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S2215-0366(17)30167-0","article-title":"ADHD in children and young people: prevalence, care pathways, and service provision","volume":"5","author":"Sayal","year":"2018","journal-title":"Lancet Psychiatr"},{"key":"10.1016\/j.jpeds.2023.02.013_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1056-4993(18)30106-8","article-title":"Epidemiology of ADHD in school-age children","volume":"9","author":"Scahill","year":"2000","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jpeds.2023.02.013_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9343(92)90229-5","article-title":"Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia","volume":"93","author":"McMurtry","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.jpeds.2023.02.013_bib25","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1210\/jc.2009-2152","article-title":"Identification of a second kindred with familial hypocalciuric hypercalcemia type 3 (FHH3) narrows localization to a <3.5 megabase pair region on chromosome 19q13.3","volume":"95","author":"Nesbit","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2023.02.013_bib26","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.12688\/f1000research.20344.1","article-title":"A Hong Kong Chinese kindred with familial hypocalciuric hypercalcaemia caused by AP2S1 mutation","volume":"8","author":"Wong","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.jpeds.2023.02.013_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/pch\/pxy093","article-title":"Evaluation of the child with global developmental delay and intellectual disability","volume":"23","author":"Belanger","year":"2018","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.jpeds.2023.02.013_bib28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/adc.2005.078147","article-title":"Investigation of global developmental delay","volume":"91","author":"McDonald","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2023.02.013_bib29","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/archdischild-2016-311271","article-title":"Current evidence-based recommendations on investigating children with global developmental delay","volume":"102","author":"Mithyantha","year":"2017","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2023.02.013_bib30","doi-asserted-by":"crossref","first-page":"e903","DOI":"10.1542\/peds.2014-1839","article-title":"Comprehensive evaluation of the child with intellectual disability or global developmental delays","volume":"134","author":"Moeschler","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2023.02.013_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11845-015-1284-7","article-title":"Unexplained developmental delay\/learning disability: guidelines for best practice protocol for first line assessment and genetic\/metabolic\/radiological investigations","volume":"185","author":"O'Byrne","year":"2016","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.jpeds.2023.02.013_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1469-7610.1987.tb00212.x","article-title":"Cognitive abilities and behavioural characteristics of children with idiopathic infantile hypercalcaemia","volume":"28","author":"Udwin","year":"1987","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.jpeds.2023.02.013_bib33","doi-asserted-by":"crossref","first-page":"7617254","DOI":"10.1155\/2019\/7617254","article-title":"Symptomatic hypercalcemia in patients\u00a0with primary hyperparathyroidism is associated with severity of disease, Polypharmacy, and comorbidity","volume":"2019","author":"Aresta","year":"2019","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jpeds.2023.02.013_bib34","doi-asserted-by":"crossref","first-page":"e0127574","DOI":"10.1371\/journal.pone.0127574","article-title":"Parathyroid hormone, cognitive function and dementia: a systematic review","volume":"10","author":"Lourida","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2023.02.013_bib35","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/jnr.22391","article-title":"Diverse roles of extracellular calcium-sensing receptor in the central nervous system","volume":"88","author":"Bandyopadhyay","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jpeds.2023.02.013_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.beem.2013.03.001","article-title":"Roles of the calcium sensing receptor in the central nervous system","volume":"27","author":"Ruat","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2023.02.013_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ceca.2003.10.008","article-title":"Calcium-sensing receptor in the brain","volume":"35","author":"Yano","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.jpeds.2023.02.013_bib38","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.3390\/molecules24142546","article-title":"The nervous system relevance of the calcium sensing receptor in Health and disease","volume":"24","author":"Giudice","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jpeds.2023.02.013_bib39","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/tra.12335","article-title":"Forty years of clathrin-coated vesicles","volume":"16","author":"Robinson","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.jpeds.2023.02.013_bib40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm3151","article-title":"Molecular mechanism and physiological functions of clathrin-mediated endocytosis","volume":"12","author":"McMahon","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jpeds.2023.02.013_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fncel.2018.00027","article-title":"Revisiting the role of clathrin-mediated endoytosis in synaptic vesicle recycling","volume":"12","author":"Milosevic","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jpeds.2023.02.013_bib42","doi-asserted-by":"crossref","first-page":"41620","DOI":"10.1038\/srep41620","article-title":"Adaptor Protein 2 (AP-2) complex is essential for functional axogenesis in hippocampal neurons","volume":"7","author":"Kyung","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpeds.2023.02.013_bib43","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s12035-017-0436-3","article-title":"Adaptor complex 2 controls dendrite morphology via mTOR-dependent expression of GluA2","volume":"55","author":"Koscielny","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jpeds.2023.02.013_bib44","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/hmg\/ddab076","article-title":"Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2","volume":"30","author":"Hannan","year":"2021","journal-title":"Hum Mol Genet"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347623001269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347623001269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:13:25Z","timestamp":1766110405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347623001269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":43,"alternative-id":["S0022347623001269"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2023.02.013","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurodevelopmental Abnormalities in Patients with Familial Hypocalciuric Hypercalcemia Type 3","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2023.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113367"}}